Duke-UNC Clinical Hematology Research Career Development Program

杜克大学-北卡罗来纳大学临床血液学研究职业发展计划

• 批准号: 7488790
• 负责人: Marilyn J Telen
• 金额: $ 39.68万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-28 至 2011-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7488790
• 关键词: Academic Medical Centers; Area; Basic Science; Benign; Blood; Clinical; Clinical Research; Clinical Trials; Commit; Educational Curriculum; Educational process of instructing; Ensure; Extramural Activities; Faculty; Fruit; Funding; Genetic; Genomics; Goals; Health Policy; Heart; Hematology; Hemoglobinopathies; Hemostatic function; Institutes; Lead; Lung; Master' s Degree; Mediation; Medical; Medical center; Mentored Clinical Scientist Development Program; Mentors; NCI Scholars Program; Non-Malignant; North Carolina; Outcome; Pharmacogenetics; Program Development; Purpose; Range; Research; Research Personnel; Research Training; Thrombosis; Training; Translating; Translational Research; Universities; career; design; experience; multidisciplinary; patient oriented research; programs; response; skills

DESCRIPTION (provided by applicant): Duke University Medical Center (DUMC) and the University of North Carolina at Chapel Hill jointly propose a Clinical Hematology Research Career Development Program (K12 CHRCDP) in response to the National Heart, Lung and Blood Institute RFA-HL-06-006. Duke and UNC have long traditions of collaborative basic and clinical research in non-malignant hematology. We now propose to establish a program to train scholars in clinical research in areas of non-malignant hematology that are well established strengths of our medical center, namely hemoglobinopathies, hemostasis and thrombosis and trasnsfusion. The purpose of the present application is therefore to ensure high quality patient-oriented research training at Duke and UNC through the provision of a clinical, didactic and experiential program for scholars who are committed to academic clinical research careers focusing on benign hematology. This CHRCDP will include a didactic and clinical curriculum designed to teach scholars the broad array of skills needed to perform clinical research and to establish successful academic research careers in nonmalignant hematology. Each scholar will have the opportunity to earn a master's degree in either clinical research or in medical genomics. In addition, we propose four primary research tracks that our trainees can enter for their mentored research experience in non-malignant hematology. Each has at least two Lead Mentors, and there are numerous faculty at Duke and UNC who will serve as secondary mentors. Our 4 tracks are (1) Translational Research, (2) Genetics and Pharmacogenetics; (3) Clinical Trials; and (4) Outcomes/Health Policy. This combination of clinical and didactic training and a mentored research experience will prepare scholars for submission of applications for extramural funding for their ongoing research program and for successful negotiation of their research careers. The long-range goal of this program is thereby to help ensure an adequate supply of well trained researchers who will be able to confront the clinical problems of non-malignant hematology through well-designed, skillfully conducted and multidisciplinary clinical research and who will be skilled in translating the fruits of basic research into clinical practice.

描述（由申请人提供）： 杜克大学医学中心（DUMC）和查佩尔山的北卡罗来纳州大学联合提出了临床血液学研究职业发展计划（K12 CHRCDP），以响应国家心肺血液研究所RFA-HL-06-006。杜克大学和杜克大学在非恶性血液学的基础和临床研究方面有着悠久的合作传统。我们现在建议建立一个计划，以培养非恶性血液学领域的临床研究学者，这些领域是我们医学中心的优势，即血红蛋白病，止血和血栓形成和输血。因此，本申请的目的是通过为致力于关注良性血液学的学术临床研究事业的学者提供临床、教学和体验计划来确保在杜克和杜克大学进行高质量的以患者为导向的研究培训。 该CHRCDP将包括教学和临床课程，旨在教授学者进行临床研究所需的广泛技能，并在非恶性血液学领域建立成功的学术研究生涯。每位学者将有机会获得临床研究或医学基因组学硕士学位。此外，我们提出了四个主要的研究轨道，我们的学员可以进入他们的指导非恶性血液学研究经验。每个学校至少有两名首席导师，杜克和杜克大学的许多教师将担任二级导师。我们的四个轨道是（1）转化研究，（2）遗传学和药物遗传学;（3）临床试验;和（4）结果/健康政策。这种临床和教学培训以及指导研究经验的结合将为学者们提交其正在进行的研究计划的校外资助申请以及成功谈判其研究生涯做好准备。该计划的长期目标是帮助确保训练有素的研究人员的供应充足，他们将能够通过精心设计，巧妙地进行和多学科的临床研究来应对非恶性血液学的临床问题，并将熟练地将基础研究成果转化为临床实践。